June 8 (Reuters) - Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is not a cause for alarm, a large new data analysis ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Section 1. Purpose. The President relies on subordinates in the executive branch to help him faithfully execute the laws and advance the priorities for which he was elected by the American people.

It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

SpaceX's historic IPO is dominating headlines, but some on Wall Street say there could be another major change ahead for one of Elon Musk's other companies. After its public debut in what's expected ...

New Mexico is one of six states that has begun using artificial intelligence to comply with a major Medicaid overhaul contained in the “One Big Beautiful Bill Act” that President Donald Trump signed ...

Julia Sullivan is a health and fitness writer, editor and content strategist well as a certified personal trainer. Her byline is in many publications from Harper's Bazaar to SELF Magazine to brand ...

The use of GLP-1 medications for weight loss continues to rise. One drawback associated with GLP-1 medications is that weight loss not only includes fat loss, but muscle loss as well. A new study ...

Almost half of patients who received etavopivat showed a hemoglobin response of 1g/dL or greater at week 24, compared to 7.2% of those on placebo. (Getty stock photo) Novo Nordisk is gearing up to ...

The water restrictions taking effect Monday in Raleigh are expected to last more than a month, according to a city spokesperson. City of Raleigh environmental coordinator Ed Buchan estimated that the ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...